Resources

LATEST BLOGS

10 cose da preparare per il Sunshine Reporting in Italia

by May Khan | Aug 25, 2025 | Blog

READ MORE

Trasferimenti di Valore Non Soggetti a Obbligo di Rendicontazione: 10 Casi che Non Devi Dichiarare

by Mauro Teresi | Aug 5, 2025 | Blog

READ MORE

Riepilogo del Webinar — Gli obblighi derivanti dal Sunshine Act Italiano. Come prepararsi?

by May Khan | July 24, 2025 | Blog

READ MORE

Scenari di rendicontazione meno noti ed esenzioni chiave ai sensi della Legge sulla Trasparenza Sanitaria

by May Khan | July 14, 2025 | Blog

READ MORE

Guida per i professionisti della compliance alla gestione della rendicontazione prevista dalla Sunshine Act italiana

by May Khan | July 10, 2025 | Blog

READ MORE

Dentro il Sunshine Compliance Dialogue 2025: Riepilogo Completo e Spunti Chiave

by May Khan | Jun 16, 2025 | Blog

READ MORE

Una lettura del Sunshine Act italiano con focus sul GDPR

by May Khan | Jun 11, 2025 | Blog

READ MORE

Cosa devono cercare le aziende MedTech in un partner per la rendicontazione della trasparenza

by May Khan | Jun 4, 2025 | Blog

READ MORE

BLOGS

INDUSTRY PERSPECTIVES

Transparency & HCP Engagement Conference 2025: Global Insights for Local Compliance

by May Khan – Vector Health | Aug 20, 2025

READ MORE

Trasparenza Veterinaria sotto i Riflettori: il Sunshine Act italiano guida dove la normativa statunitense sulla trasparenza non arriva.

by May Khan – Vector Health | Jul 30, 2025

READ MORE

Learning from U.S. Mistakes: How Italian Manufacturers Can Avoid Compliance Pitfalls with the Sunshine Act

by ENZO SEIDI – Vector Health | Dec 10, 2024

READ MORE

The UK Considers a 'Sunshine Act' of Its Own

Sunshine Act: Towards the Platform for Transparent Healthcare in Italy

by J. Carlos Suarez & Marialaura Boni – Osborne Clarke | Nov 3, 2023

READ MORE

The Italian Sunshine Act

by Mauro Teresi – Simmons & Simmons | Nov 2, 2023

READ MORE

Italian Sunshine Act: Transparency Reporting Requirements

by May Khan – Vector Health | May 8, 2025

READ MORE

CREDIBLE RESOURCES

Vector Health, a leader in compliance services for the life sciences industry, offers a cutting-edge solution with the Vector Health Transparency, Analytics, and Risk Management Platform. This powerful platform, developed by a team of drug and device compliance experts, delivers purpose-built software solutions and services. Vector Health empowers compliance and legal professionals to effortlessly navigate the complex compliance lifecycle, including spend research, transparency reporting, monitoring, analytics, and high-risk spend audits on a global scale. With a strong presence across the US, EU, and APAC regions and 24/7 world-class support, Vector Health sets the industry standard for excellence in compliance solutions.

VC BioLaw specializes in providing expert legal services tailored for the life sciences and healthcare sector. VC BioLaw is renowned for its in-depth knowledge and vast experience in pharmaceuticals, biotechnology, and medical devices. The firm’s services encompass various legal aspects, including regulatory and compliance matters, licensing and collaboration agreements, and intellectual property protection. With a dedicated team of experienced attorneys, VC BioLaw excels in delivering customized legal solutions to meet the unique challenges and demands of the life sciences industry.

Liles Parker is a distinguished Washington, D.C.-based law firm, specializing in nationwide representation of healthcare providers and suppliers facing Medicare, Medicaid, and private payor audits, investigations, and revocation actions. The firm boasts a team of attorneys, including former federal prosecutors, certified billers, coders, and compliance officers. Their expertise encompasses corporate governance, business transactions, regulatory compliance, and health law, making them prominent figures in the field. Liles Parker’s commitment to safeguarding their clients’ interests is underscored by their “AV” rating from Martindale-Hubbell, recognizing their exceptional legal ability and unwavering dedication to professional standards and ethics. At Liles Parker, your success is their priority, and they consistently deliver quality, innovative representation in the most cost-effective manner possible.

 

 

The European Federation of Pharmaceutical Industries and Associations (EFPIA) represents the biopharmaceutical industry operating in Europe. Through its direct membership of 37 national associations, 40 leading pharmaceutical companies and a growing number of small and medium-sized enterprises (SMEs), EFPIA’s mission is to create a collaborative environment that enables our members to innovate, discover, develop and deliver new therapies and vaccines for people across Europe, as well as contribute to the European economy.

MedTech Europe is a prominent alliance of leading medical technology companies, representing the industry’s diverse and innovative landscape. Committed to advancing healthcare for all, their member companies deliver cutting-edge medical technology, enabling patients to lead healthier lives. MedTech Europe plays a vital role in shaping healthcare policy, advocating for industry best practices, and promoting the highest standards of quality and patient safety. Their collaborative approach fosters dialogue between key stakeholders, from governments to healthcare professionals, ensuring that innovative medical solutions reach those who need them. With a strong focus on ethics and transparency, MedTech Europe is dedicated to upholding the highest standards of integrity within the industry. Through their continuous efforts, they drive medical technology’s growth and development, fostering a healthier world for everyone.

USEFUL LINKS